Coronavirus Update, 1st May 2020
We trust you and your families are safe and in good health. As we enter a potentially new phase in this pandemic, with preparations turning to steps back toward normalcy after several challenging weeks, we are grateful for the continued efforts and dedication of our employees to ensure uninterrupted medicines supply to our customers and patients. Our teams have been working relentlessly – overtime, on weekends and with additional shifts – to bring life-changing therapies all over the world, and we thank you for your partnership and confidence in us.
Our hearts have warmed at the stories we hear on an almost daily basis, of the lives that we are touching, and we can see the impact of all the good news with positive attitudes, hopeful spirits and engaged employees. We want you to know that your feedback and gratitude are shared across our teams and sites and are deeply appreciated during these difficult times.
Employee safety remains our number one priority and we’ve expanded our efforts in that regard per our previous communication. Having invested in implementation of onsite clinics and medical staff at our facilities in Philadelphia and Rockford has made a huge impact on not only our ability to be proactive and more precise in managing potential COVID-19 related health issues but also providing comfort to our front-line heroes and heroines, reassuring them of their continued safety while at work and ensuring consistency in staffing. This increased attention, proactive monitoring and rapid deployment of PPE and numerous other safety initiatives have allowed us to stay focused on meeting customer and patients’ needs while maintaining smooth operations across our global network.
We are fortunate that our business and operations are running smoothly and we are thankful for the opportunity to collaborate with you in the shared goal of improving patients’ lives. Across all of our segments, demand remains strong, as COVID has increased demand for adjacent therapies across many categories, and we have been energized with the response of our teams to provide our industry leading customer experience. From early phase clinical trials through commercial launches and continued supply, it is a privilege to be your bridge between life-changing therapies and patients.
The requests for additional help with COVID-19 treatments and experimental vaccines are high, in addition to the other medicines that we are providing around the world and we appreciate your flexibility in those cases where we may experience slight delays. As mentioned, our Operations, Procurement, Business Development and Project Management professionals are working around the clock to maintain business as usual and to ensure any potential delays are mitigated. As you may know, lead times for some materials have been extended and we are working with all of our customers to secure long term supplies and leverage our networks as best as possible. We have been making significant investments and implemented costly measures to ensure uninterrupted supply chains of medicine to our customers and their patients.
We wish to express our utmost gratitude to all our customers and partners for your trust, collaboration and support. Together, we have surmounted a few weeks of unprecedented challenges and delivered on our mission of maintaining uninterrupted supply of life changing therapies to patients worldwide.
Salim Haffar, CEO
Please feel free to download and view all of our Coronavirus updates below